Precision Medicine in Breast Cancer: Do MRI Biomarkers Identify Patients Who Truly Benefit from the Oncotype DX Recurrence Score(®) Test?

The aim of this study was to combine breast MRI-derived biomarkers with clinical-pathological parameters to identify patients who truly need an Oncotype DX Breast Recurrence Score(®) (ODXRS) genomic assay, currently used to predict the benefit of adjuvant chemotherapy in ER-positive/HER2-negative ea...

Descripción completa

Detalles Bibliográficos
Autores principales: Galati, Francesca, Magri, Valentina, Moffa, Giuliana, Rizzo, Veronica, Botticelli, Andrea, Cortesi, Enrico, Pediconi, Federica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9689656/
https://www.ncbi.nlm.nih.gov/pubmed/36359573
http://dx.doi.org/10.3390/diagnostics12112730

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9689656/
https://www.ncbi.nlm.nih.gov/pubmed/36359573
http://dx.doi.org/10.3390/diagnostics12112730

Ejemplares similares